PMID: 6169426Aug 1, 1981Paper

Familial acute myelogenous leukemia associated with RNA virus and polymorphism of 1qh+

Cancer Genetics and Cytogenetics
N SadamoriH Sawada

Abstract

In order to investigate the genetic background of leukemogenesis of two brothers with acute myelogenous leukemia (AML), they and their family members were studied genetically, immunologically, virologically, and cytogenetically. Their parents were first cousins once removed and had the same or a very close type of human leukocyte antigen (HLA) and blood groups. In all five non-leukemic family members the immunoglobulin G (IgG) level was elevated, and in two healthy siblings the IgM level was beyond the normal range. The RNA reverse transcriptase activity in serum of the younger brother (Case 2) with AML was elevated. A cytogenetic study of the family revealed polymorphism of 1qh+. Based on these findings, we discuss the genetic and environmental factors of familial leukemia.

References

Jul 15, 1977·International Journal of Cancer. Journal International Du Cancer·H SawadaY Ito
Feb 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·T W MakD Housman
Jul 7, 1971·Nature: New Biology·A T SumnerR A Buckland
Nov 1, 1972·Experimental Cell Research·A T Sumner
Dec 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·S A Latt
Oct 1, 1974·Cancer·S KuritaK Ota
Jan 1, 1968·Archives of Internal Medicine·P G RigbyH M Lemon
Nov 1, 1969·Proceedings of the Royal Society of Medicine·G Hambleton, D G Cottom
Apr 12, 2003·Leukemia & Lymphoma·J KuruvillaJ H Lipton
Jan 1, 1964·Proceedings of the National Academy of Sciences of the United States of America·H HANAFUSAH RUBIN
Apr 29, 1965·The New England Journal of Medicine·C W HEATH, W C MOLONEY
Apr 1, 1937·The Journal of Hygiene·S N Ardashnikov

❮ Previous
Next ❯

Citations

Feb 1, 1987·Cancer Genetics and Cytogenetics·R S VermaH Dosik

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

© 2021 Meta ULC. All rights reserved